Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV child-A cirrhosis
Background: Hepatitis C virus (HCV) infection is associated with an increased risk of renal disease. The correlation between HCV and glomerular damage is well recognized, but limited data are available on HCV-mediated tubular damage. Recently, several novel direct antiviral agents (DAAs) have been approved for HCV treat- ment, but the effects of HCV clearance on renal involvement (RI) has not been fully characterized.